|
|
 Previous Article | Table of Contents | Next Article 
Identification of T-Cell Epitopes on the Rhesus Polypeptides in Autoimmune Hemolytic Anemia
Robert N. Barker,
Andrew M. Hall,
Graham R. Standen,
Jeff Jones, and
Christopher J. Elson
From the Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK; the Molecular Haematology Unit, Bristol Royal Infirmary, Bristol, UK; the International Blood Group Reference Laboratory, Bristol, UK; and the Department of Pathology and Microbiology, University of Bristol, Bristol, UK.
We have shown previously that the Rhesus (Rh) polypeptides are the commonest targets for pathogenic anti-red blood cell (RBC) autoantibodies in patients with autoimmune hemolytic anemia (AIHA). The aim of the current work was to determine whether activated T cells from such patients also mount recall responses to epitopes on these proteins. Two panels of overlapping 15-mer peptides, corresponding to the sequences of the 30-kD Rh proteins associated with expression of the D and Cc/Ee blood group antigens, were synthesized and screened for the ability to stimulate the in vitro proliferation of mononuclear cells from the peripheral blood or spleen of nine AIHA cases. Culture conditions were chosen that favor recall proliferation by previously activated T cells, rather than primary responses. In seven of the patients, including all four cases with autoantibody to the Rh proteins, two or more peptides elicited proliferation, but cells from eight of nine patients with other anemias and seven of nine healthy donors failed to respond to the panels. Multiple peptides were also stimulatory in two positive control donors who had been alloimmunized with Rh D-positive RBCs. Six different profiles of peptides elicited responses in the AIHA patients, and this variation may reflect the different HLA types in the group. Stimulatory peptides were identified throughout domains shared between, or specific to, each of the related 30-kD Rh proteins, but T cells that responded to nonconserved regions did not cross-react with the alternative sequences. Anti-major histocompatibility complex class II antibodies blocked the responses and depletion experiments confirmed that the proliferating mononuclear cells were T cells. Notably, splenic T cells that proliferated against multiple Rh peptides also responded to intact RBCs. We propose that pathogenic autoantibody production in many cases of AIHA is driven by the activation of T-helper cells specific for previously cryptic epitopes on the Rh proteins.
Blood, Vol. 90 No. 7 (October 1), 1997:
pp. 2701-2715
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Zou, S. Hannier, L. S. Cairns, R. N. Barker, A. J. Rees, A. N. Turner, and R. G. Phelps
Healthy Individuals Have Goodpasture Autoantigen-Reactive T Cells
J. Am. Soc. Nephrol.,
February 1, 2008;
19(2):
396 - 404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. J. Ward, A. M. Hall, L. S. Cairns, A. S. Leggat, S. J. Urbaniak, M. A. Vickers, and R. N. Barker
Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia
Blood,
January 15, 2008;
111(2):
680 - 687.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Hall, F. J. Ward, C.-R. Shen, C. Rowe, L. Bowie, A. Devine, S. J. Urbaniak, C. J. Elson, and R. N. Barker
Deletion of the dominant autoantigen in NZB mice with autoimmune hemolytic anemia: effects on autoantibody and T-helper responses
Blood,
December 15, 2007;
110(13):
4511 - 4517.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. J. Pickford, A. J.M. Watson, and R. N. Barker
Different Forms of Helper Tolerance to Carcinoembryonic Antigen: Ignorance and Regulation
Clin. Cancer Res.,
August 1, 2007;
13(15):
4528 - 4537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Sukati, H. G. Watson, S. J. Urbaniak, and R. N. Barker
Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura
Blood,
May 15, 2007;
109(10):
4528 - 4538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Hall, M. A. Vickers, E. McLeod, and R. N. Barker
Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells
Blood,
March 1, 2005;
105(5):
2007 - 2015.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Hall, L. S. Cairns, D. M. Altmann, R. N. Barker, and S. J. Urbaniak
Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice
Blood,
March 1, 2005;
105(5):
2175 - 2179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-R. Shen, A.-R. Youssef, A. Devine, L. Bowie, A. M. Hall, D. C. Wraith, C. J. Elson, and R. N. Barker
Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia
Blood,
November 15, 2003;
102(10):
3800 - 3806.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Hall, F. J. Ward, M. A. Vickers, L.-M. Stott, S. J. Urbaniak, and R. N. Barker
Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen
Blood,
December 15, 2002;
100(13):
4529 - 4536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.-M. Stott, R. N. Barker, and S. J. Urbaniak
Identification of alloreactive T-cell epitopes on the Rhesus D protein
Blood,
December 15, 2000;
96(13):
4011 - 4019.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
